Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
LFSCvsBBPETF Comparison
F/m Emerald Life Sciences Innovation ETF (LFSC) belongs to the Life Sciences segment. Virtus LifeSci Biotech Products ETF (BBP) is part of the Tomorrow's Treatments segment. LFSC's top 3 sector exposures are Health Care and Sovereign. In contrast, BBP's top sector exposures are Health Care Both LFSC and BBP have the same Total Expense Ratio (TER) of 0.79%. LFSC is down -4.3% year-to-date (YTD) with +$5M in YTD flows. BBP performs better with 6.54% YTD performance, and +$4M in YTD flows. Run a side-by-side ETF comparison of LFSC and BBP below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
LFSC vs BBP performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | LFSC BBP | -2.61%+3.49% | -9.88%+9.58% | -4.30%+6.54% | +55.33%+42.80% | n/a+83.49% | n/a+60.18% |
| Flows | LFSC BBP | +$6M+$4M | +$6M+$16M | +$5M+$4M | +$16M+$19M | -+$19M | -+$9M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | LFSC BBP | +21.93%+24.65% | +28.55%+25.47% | n/a+23.56% | n/a+26.14% |
| Max drawdown | LFSC BBP | -12.82%-7.42% | -19.03%-17.97% | n/a-25.54% | n/a-38.24% |
| Max drawdown duration | LFSC BBP | 76d32d | 70d106d | n/a292d | n/a915d |
LFSC | BBP | |
Last sale 3/12/2026 at 1:30 PM | $33.82 | $81.68 |
| Previous close 03/11/2026 | $35.01 | $84.32 |
| Consolidated volume 03/11/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
LFSC | BBP | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
LFSC | BBP | |
|---|---|---|
| Last price | $33.82 | $81.68 |
| 1D performance | -3.41% | -3.13% |
| AuM | $93.79 M | $50.98 M |
| E/R | 0.79% | 0.79% |
LFSC | BBP | |
|---|---|---|
| Management strategy | Active | Passive |
| Provider | Emerald Group | VIRTUS Investment Partners |
| Benchmark | - | LifeSci Biotechnology Products Index |
| N° of holdings | 34 | 58 |
| Asset class | - | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | October 31, 2024 | December 16, 2014 |
| ESG | No | No |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Top 15 holdings
How have the LFSC and BBP ETFs performed in 2026?
As of March 11, 2026, LFSC is down -4.3% year-to-date (YTD), while BBP has returned 6.54%. That puts BBP better performer ahead so far this year.
Which ETF is attracting more investor money: LFSC or BBP?
Year-to-date, the LFSC ETF saw +$5M in flows, compared to +$4M for BBP.
Which ETF is more volatile: LFSC or BBP?
Over the past year, LFSC had a volatility of 28.55%, while BBP experienced 25.47%.
Which ETF is bigger: LFSC or BBP?
As of March 11, 2026, LFSC holds $93.79 M in assets under management (AUM), while BBP manages $50.98 M.
What sectors do the LFSC and BBP ETFs invest in?
LFSC leans toward sectors like Health Care. Meanwhile, BBP focuses on Health Care.
What are the top holdings of the LFSC ETF and BBP ETF?
LFSC top holdings include COGENT BIOSCIENCES, LIVANOVA and GUARDANT HEALTH INC. BBP holds in its top three: DAY ONE BIOPHARMACEUTICALS, DYNAVAX TECHNOLOGIES and AMICUS THERAPEUTICS.
Which ETF is more diversified: LFSC or BBP?
LFSC holds 42 securities with 68.94% of its assets in the top 15. BBP has 63 securities and a top 15 weight of 30.11%.
Active Trader Report: Use of Leveraged & Inverse ETFs Way Up
Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.
